University of Louisville researchers have received $3.6 million in new grant funding to study the role of arsenic exposure in causing cancer and other major health concerns.
EMA seeks to ease the regulatory burden on biosimilar developers, following push by FDA
The European Medicines Agency earlier this week proposed reducing the regulatory requirements for biosimilar developers due to what it calls “the advances in the analytical